| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Matinas BioPharma Holdings, Inc. | Chief Scientific Officer | Common Stock, par value $0.0001 per share | 1.92M | Sep 3, 2021 | Direct | ||
| Matinas BioPharma Holdings, Inc. | Chief Scientific Officer | Stock Option (right to Buy) | 275K | Dec 14, 2021 | Direct | ||
| Matinas BioPharma Holdings, Inc. | Chief Scientific Officer | Series B Preferred Stock | 0 | Jun 19, 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| MTNB | Matinas BioPharma Holdings, Inc. | Dec 14, 2021 | 1 | $0 | 4 | Dec 15, 2021 | Chief Scientific Officer |
| MTNB | Matinas BioPharma Holdings, Inc. | Sep 3, 2021 | 1 | $0 | 4 | Sep 14, 2021 | Chief Scientific Officer |
| MTNB | Matinas BioPharma Holdings, Inc. | Jun 19, 2021 | 3 | $0 | 4 | Jun 24, 2021 | Chief Scientific Officer |